Stockholm Stock Exchange | Mid Cap
Bonesupport
+14.71%
Latest
+14.71%
3 months
SEBCarnegieABG Sundal CollierSEB Equities

Price Targets For Bonesupport

AnalystPrice TargetDateUpside
SEB78 SEKJul 8
+14.71%
Carnegie105 SEKMay 30
ABG Sundal Collier95 SEKMay 19
SEB Equities58 SEKOct -21

About The Company

Bonesupport Holding AB is a Swedish pharmaceutical company that develops and markets the synthetic injectable bone graft substitute Cerament, which is used in the treatment of skeletal injuries. Bonesupport was founded in the early 2000s as a research company in Lund by orthopedist Lars Lidgren. Wikipedia